Valuation Merck & Co., Inc.

Equities

Market Closed - Nyse Other stock markets 16:00:31 2026-05-11 EDT			5-day change	1st Jan Change
111.28 ^USD	-0.09%		-1.62%	+5.72%

05-11	Erasca Teams With Merck on AURORAS-1 Cancer Study	MT
05-07	The Rally Spreads

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	193,588	281,302	276,259	251,648	261,258	274,842	-	-
Change	-	45.31%	-1.79%	-8.91%	3.82%	5.2%	-	-
Enterprise Value (EV) ¹	218,594	298,801	304,221	275,517	296,032	309,490	296,433	279,674
Change	-	36.69%	1.81%	-9.44%	7.45%	4.55%	-4.22%	-5.65%
P/E ratio	14.9x	19.4x	779x	14.8x	14.5x	49.6x	13.4x	11.6x
PBR	5.07x	6.12x	7.34x	5.44x	5.01x	5.65x	4.68x	3.85x
PEG	-	1.7x	-8x	0x	1.81x	-0.7x	0x	0.7x
Capitalization / Revenue	3.97x	4.75x	4.6x	3.92x	4.02x	4.11x	3.91x	3.63x
EV / Revenue	4.49x	5.04x	5.06x	4.29x	4.55x	4.63x	4.21x	3.69x
EV / EBITDA	10.5x	11.3x	30.2x	9.88x	9.08x	17.3x	8.72x	7.63x
EV / EBIT	12.4x	13.3x	49x	11.8x	11.1x	23.6x	10.2x	8.7x
EV / FCF	25.2x	20.3x	33.3x	15.2x	24x	26.4x	13.2x	11.9x
FCF Yield	3.97%	4.92%	3.01%	6.57%	4.18%	3.79%	7.6%	8.44%
Dividend per Share ²	2.64	2.8	2.96	3.12	3.28	3.33	3.463	3.674
Rate of return	3.44%	2.52%	2.72%	3.14%	3.12%	2.99%	3.11%	3.3%
EPS ²	5.14	5.71	0.14	6.74	7.28	2.241	8.312	9.604
Distribution rate	51.4%	49%	2,114%	46.3%	45.1%	149%	41.7%	38.3%
Net sales ¹	48,704	59,283	60,115	64,168	65,011	66,849	70,372	75,703
EBITDA ¹	20,910	26,431	10,083	27,897	32,617	17,864	34,004	36,649
EBIT ¹	17,696	22,522	6,211	23,398	26,779	13,097	29,055	32,157
Net income ¹	13,049	14,519	365	17,117	18,254	5,556	20,425	23,378
Net Debt ¹	25,006	17,499	27,962	23,869	34,774	34,648	21,591	4,832
Reference price ²	76.64	110.95	109.02	99.48	105.26	111.28	111.28	111.28
Nbr of stocks (in thousands)	2,525,944	2,535,396	2,534,023	2,529,636	2,482,023	2,469,824	-	-
Announcement Date	2/3/22	2/2/23	2/1/24	2/4/25	2/3/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MERCK & CO., INC.	49.69x	4.63x	17.34x	2.99%	275B
ELI LILLY AND COMPANY	27.83x	10.14x	20.87x	0.72%	846B
JOHNSON & JOHNSON	23.65x	5.46x	14.84x	2.41%	533B
ABBVIE INC.	24.57x	6.1x	12.42x	3.41%	356B
ROCHE HOLDING AG	16.67x	4.18x	10.31x	3.18%	324B
ASTRAZENECA PLC	22.88x	4.76x	13.54x	1.83%	282B
NOVARTIS AG	20.12x	5.43x	13.2x	3.09%	278B
NOVO NORDISK A/S	13.18x	4.82x	9.89x	3.84%	203B
AMGEN INC.	21.33x	5.83x	10.12x	3.04%	179B
GILEAD SCIENCES, INC.	-47.96x	5.67x	34.54x	2.46%	163B
Average	17.20x	5.70x	15.71x	2.7%	343.84B
Weighted average by Cap.	21.72x	6.42x	16.00x	2.34%